Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07437300

Influence of a High-fiber Diet on the Microbiota and the Response to Immunotherapy in Patients Treated for Melanoma.

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The underlying hypothesis of the study is that melanoma patients treated with immunotherapy, whether in an adjuvant or curative setting, who consume more fiber would respond better to immunotherapy: either no recurrence in the case of adjuvant treatments, or no progression (disease stability, partial or complete response) in the case of curative treatments. The primary objective is to evaluate the association between total dietary fiber intake quantified using the FiberTAG questionnaire and response to immunotherapy treatment in patients treated for melanoma in a curative or adjuvant setting

Conditions

Timeline

Start date
2026-02-25
Primary completion
2026-05-15
Completion
2027-02-01
First posted
2026-02-27
Last updated
2026-02-27

Source: ClinicalTrials.gov record NCT07437300. Inclusion in this directory is not an endorsement.